Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants. - Hsu CH; Chang TY; Chang YM; Lin SH; Chen TN; Hsu KH; You JJ (Frontiers in immunology, 2026)